InvestorsHub Logo
Followers 30
Posts 5046
Boards Moderated 0
Alias Born 01/07/2020

Re: None

Wednesday, 06/17/2020 6:02:47 PM

Wednesday, June 17, 2020 6:02:47 PM

Post# of 425648
Yahoo - input on yesterdays settelement information - thanks to Stock Revealer:

[stock_revealer

stock_revealer17 hours ago

Interesting to see that Apotex knew they were about to get sued if they attempted to launch. By settling early before the patents appeal conclusion, they get the same end result...exclusivity of Vascepa until August 2029 while at the same time getting the API before the patents expire directly from Amarin early (in 2020) so their generic will be suitable when they are able to go commercial in 2029. They will also save money from their lawyers. Amarin was very smart to negotiate zero cash with Apotex and goes to show how strong Amarin's position really is to all shareholders and new investors.

Apotex was smart to plan ahead since they know they are not ready for launch and at the same time they know that Fish & Richardson will execute....which means the appeal process is just going to be another checkbox.

The Apotex news is a positive sign and might even convince Hikma and Dr.Reddy's to give up. Hikma&Dr. Reddy's will lose and the stock market does not yet reflect this but will soon. End of summer will be the explosion we've been waiting for...

**EVAPORATE
**China expansion
**Europe expansion
**Appeal win
**COVID-19 trial results/quote]

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News